Companies / Immucell Corp /De/ / Activity
Activity — Immucell Corp /De/
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Brigham Michael F Director | Exercise | Common Stock, par value $.01 per share | $146.0K | +25K +12.21% | 229,752 2.54% of shares | low |
| Mar 20, 2026 | Brigham Michael F Director | Other | Common Stock, par value $.01 per share | $146.0K | -24K -10.47% | 205,700 2.27% of shares | low |
| Apr 15, 2026 | Tomsche David Scott Director | Grant | Non Qualified Stock Options (Right to buy) | — | +12K | 11,933 0.13% of shares | low |
| Apr 16, 2025 | Tomsche David Scott Director | Grant | Non Qualified Stock Options (Right to buy) | — | +10K | 10,000 0.11% of shares | low |
| Jan 27, 2026 | te Boekhorst Paul Francis Olivier CEO | Grant | Stock Options (right to buy) | — | +110K | 110,000 1.22% of shares | low |
| Jan 27, 2026 | te Boekhorst Paul Francis Olivier CEO | Grant | Stock Options (right to buy) | — | +110K | 109,500 1.21% of shares | low |
| Jan 27, 2026 | Fiori Timothy C Executive | Grant | Stock Options (right to buy) | — | +120K | 120,000 1.33% of shares | low |
| Jan 27, 2026 | Brockmann Bobbi Jo Executive | Grant | Stock Options (right to buy) | — | +100K | 100,000 1.11% of shares | low |
| Mar 20, 2026 | Brigham Michael F Director | Exercise | Stock Options (right to buy) | — | -25K -100.00% | 0 0.00% of shares | low |